EASEE-PEARL: German Long-Term Registry for Monitoring the EASEE® Therapy for Focal Epilepsy
Real-World Data on the Long-Term Use of the EASEE® Therapy in Germany
By capturing treatment datafrom routine clinical practice, the EASEE-PEARL study aims to generate valuable insights into the long-term efficacy, safety, and usability of the EASEE® System in people with drug-resistant focal epilepsy.
Patient Experiences at the Center
EASEE-PEARL captures important insights into the use of the EASEE® System and its impact on the everyday lives of people with focal epilepsy.
Real-World Clinical Evidence
EASEE-PEARL contributes to improving the long-term care of people with focal epilepsy through data collected in routine clinical practice.
Long-Term Data on EASEE®
The study provides insights into the efficacy, tolerability, acceptance, and use of EASEE® over a period of three years.
The Study at a Glance
- Indication: Drug-resistant focal epilepsy
- Population: 135 adult patients aged 18 and older
- Intervention: Treatment with the EASEE® System as part of routine clinical care
- Study Design: Multicenter registry study in Germany
- Objective: Evaluation of efficacy, tolerability, and long-term use of the EASEE® System in a real-world setting
Study Overview
Enrollment
Baseline
Implantation
Activation
Follow-up
Study End
The Clinical Expert behind EASEE-PEARL
Prof. Dr. med. Bettina Schmitz
Head of the Department of Neurology
Stroke Unit and Berlin Epilepsy Center
Vivantes
Medical Care Center for Neurology
Interested in the EASEE-PEARL Study?
If you have any questions about EASEE-PEARL, the study team at Vivantes Hospital is happy to help.
